Key result
The combination of ACE D and AT1 C alleles was associated with increased risk of malignant ventricular arrhythmias in patients with CAD and LV dysfunction.
Why the study?
Does the presence of ACE D and AT1 C alleles increase the risk of malignant ventricular arrhythmias in patients with coronary artery disease and left ventricular dysfunction?
Case-Control (n=227)
Does the presence of ACE D and AT1 C alleles increase the risk of malignant ventricular arrhythmias in patients with coronary artery disease and left ventricular dysfunction?
The combination of ACE D and AT1 C alleles is associated with a 2.4-fold increased risk of malignant ventricular arrhythmias in Caucasian patients with CAD and reduced LVEF.
Answers are grounded in this paper and cite their sources.
May support genotyping for arrhythmia risk in CAD with LV dysfunction; leaves open prospective validation before clinical use.
OBJECTIVES: It has been reported that patients carrying the angiotensin-converting enzyme (ACE) deletion DD genotype with the angiotensin II type 1 (AT1) C allele are at increased risk for myocardial infarction. The frequency distribution of the ACE and AT1 receptor gene polymorphism and their possible relation regarding malignant ventricular arrhythmias in patients with coronary artery disease (CAD) and left ventricular dysfunction was determined. METHODS: The ACE I/D and AT1 A/C polymorphisms (using polymerase chain reaction) in 100 Caucasian patients suffering from CAD with a history of malignant ventricular arrhythmias treated with an implantable cardioverter defibrillator (ICD group) was compared to 127 age-matched Caucasian patients with CAD and no history of malignant ventricular arrhythmias (control group). All patients had reduced left ventricular ejection fraction of < 40% and were comparable regarding sex distribution, body mass index, ACE-inhibitor treatment, lipid status and duration of CAD. RESULTS: The prevalence of DD/CC in the ICD group was significantly higher (19% versus 10%, p < 0.0001). The risk for malignant ventricular arrhythmias was associated with the combination of ACE D and AT1 C alleles (odds-ratio: 2.4, 95% confidence interval 1.41 to 3.94, p < 0.001). The distribution of ACE and AT1 genotypes was not different between the two group. CONCLUSIONS: Patients with coronary artery disease and left ventricular dysfunction carrying ACE D and AT1 C alleles are at increased risk for development of malignant ventricular arrhythmias. Because of available pharmacological inhibitors, these results may have clinical implications for the prevention of sudden cardiac death.
No takes yet. Share an insight, caveat, or question.
Anahit Anvari (1999) conducted a case-control in Coronary artery disease and left ventricular dysfunction (n=227). Combination of ACE D and AT1 C alleles vs. Absence of this allele combination was evaluated on Malignant ventricular arrhythmias (OR 2.4, 95% CI 1.41-3.94, p=< 0.001). The combination of ACE D and AT1 C alleles was associated with increased risk of malignant ventricular arrhythmias in patients with CAD and LV dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: